The effect of melatonin, magnesium, and zinc on primary insomnia in long-term care facility residents in italy: A double-blind, placebo-controlled clinical trial

Journal of the American Geriatrics Society

Volumn 59, Issue 1, 2011, Pages 82-90

  Rondanelli, Mariangela ^a,b   Opizzi, Annalisa ^a,b   Monteferrario, Francesca ^a,b   Antoniello, Neldo ^c   Manni, Raffaele ^d   Klersy, Catherine ^e  

^a Faculty of Medicine   (United States)

^b UNIVERSITY OF PAVIA   (Italy)

^c ASP (Azienda di Servizi alla Persona) of Pavia   (Italy)

^d C MONDINO NATIONAL NEUROLOGICAL INSTITUTE   (Italy)

^e FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

Author keywords

dietary supplement; elderly; insomnia; magnesium; melatonin; zinc

Indexed keywords

MAGNESIUM; MELATONIN; MEZINAT; PLACEBO; UNCLASSIFIED DRUG; ZINC;

AGED; ALERTNESS; AROUSAL; ARTICLE; BEDTIME DOSAGE; BEHAVIOR; CLINICAL ARTICLE; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; FEMALE; HUMAN; INSOMNIA; ITALY; LONG TERM CARE; MALE; PARALLEL DESIGN; PEAR; PRIMARY INSOMNIA; QUALITATIVE ANALYSIS; QUALITY OF LIFE; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; SHORT FORM 36; SLEEP; VALIDATION PROCESS;

EID: 78651399199     PISSN: 00028614     EISSN: 15325415     Source Type: Journal    
DOI: 10.1111/j.1532-5415.2010.03232.x     Document Type: Article

References (49)

1. Diagnostic and Statistical Manual of Mental Disorders, 4th Ed. Washington, DC: American Psychiatric Association, 2000.
2. Richardson GS, Carskadon MA, Orav EJ, et al,. Circadian variation of sleep tendency in elderly and young adult subjects. Sleep 1982; 5: 82-94.
3. Ohayon MM, Zulley J, Guilleminault C, et al,. How age and daytime activities are related to insomnia in the general population: Consequences for older people. J Am Geriatr Soc 2001; 49: 360-366.
4. Roth T, Costa e Silva JA, Chase MH., Sleep and cognitive (memory) function: Research and clinical perspectives. Sleep Med 2001; 2: 379-387.
5. Maggi S, Langlois JA, Minicuci N, et al,. Sleep complaints in community-dwelling older persons: Prevalence, associated factors, and reported causes. J Am Geriatr Soc 1998; 46: 161-168.
6. Foley DJ, Monjan A, Simonsick EM, et al,. Incidence and remission of insomnia among elderly adults: An epidemiologic study of 6,800 persons over three years. Sleep 1999; 22: 366-372.
7. Sateia MJ, Doghramji K, Hauri PJ, et al,. Evaluation of chronic insomnia. An American Academy of Sleep Medicine review. Sleep 2000; 23: 243-308.
8. Mathews D., Review of insomnia: The sleep cycle and treatment options. Pharm Times 2003; 69: 75-87.
9. Weissman MM, Greenwald S, Nino-Murcia G, et al,. The morbidity of insomnia uncomplicated by psychiatric disorders. Gen Hosp Psychiatry 1997; 19: 245-250.
10. Hatoum HT, Kong SX, Kania CM, et al,. Insomnia, health-related quality of life and healthcare resource consumption. A study of managed-care organisation enrollees. Pharmacoeconomics 1998; 14: 629-637.
11. Sateia MJ, Nowell PD., Insomnia. Lancet 2004; 364: 1959-1973.
12. Kapur VK, Redline S, Nieto FJ, et al,. The relationship between chronically disrupted sleep and healthcare use. Sleep 2002; 25: 289-296.
13. Brassington GS, King AC, Bliwise DL., Sleep problems as a risk factor for falls in a sample of community-dwelling adults aged 64-99 years. J Am Geriatr Soc 2000; 48: 1234-1240.
14. National Institutes of Health. National Institutes of Health State of the Science Conference statement on Manifestations and Management of Chronic Insomnia in Adults, June 13-15, 2005. Sleep 2005; 28: 1049-1057.
15. Lustberg L, Reynolds CF., Depression and insomnia: Questions of cause and effect. Sleep Med Rev 2000; 4: 253-262.
16. Srinivasan V, Smits M, Spence W, et al,. Melatonin in mood disorders. World J Biol Psychiatry 2006; 7: 138-151.
17. Garzõn C, Guerrero JM, Aramburu O, et al,. Effect of melatonin administration on sleep, behavioral disorders and hypnotic drug discontinuation in the elderly: A randomized, double-blind, placebo-controlled study. Aging Clin Exp Res 2009; 21: 38-42.
18. Scheer FA, Czeisler CA., Melatonin, sleep, and circadian rhythms. Sleep Med Rev 2005; 9: 5-9.
19. Buscemi N, Vandermeer B, Hooton N, et al,. Efficacy and safety of exogenous melatonin for secondary sleep disorders and sleep disorders accompanying sleep restriction: Meta-analysis. BMJ 2006; 332: 385-393.
20. Haimov I, Laudon M, Zisapel N, et al,. Sleep disorders and melatonin rhythms in elderly people. BMJ 1994; 309: 167.
21. Bain KT., Management of chronic insomnia in elderly persons. Am J Geriatr Pharmacother 2006; 4: 168-192.
22. Schnelle JF, Alessi CA, Al-Samarrai NR, et al,. The nursing home at night: Effects of an intervention on noise, light, and sleep. J Am Geriatr Soc 1999; 47: 430-438.
23. Chung KF, Lee CK., Over-the-counter sleeping pills: A survey of use in Hong Kong and a review of their constituents. Gen Hosp Psychiatry 2002; 24: 430-435.
24. Kroczka B, Zieba A, Dudek D, et al,. Zinc exhibits an antidepressant-like effect in the forced swimming test in mice. Pol J Pharmacol 2000; 52: 403-406.
25. Nowak G, Siwek M, Dudek D, et al,. Effect of zinc supplementation on antidepressant therapy in unipolar depression: A preliminary placebo-controlled study. Pol J Pharmacol 2003; 55: 1143-1147.
26. Siwek M, Dudek D, Paul IA, et al,. Zinc supplementation augments efficacy of imipramine in treatment resistant patients: A double blind, placebo-controlled study. J Affect Disord 2009; 118: 187-195.
27. Sowa-KuÄma M, Legutko B, Szewczyk B, et al,. Antidepressant-like activity of zinc: Further behavioral and molecular evidence. J Neural Transm 2008; 115: 1621-1628.
28. Laires MJ, Monteiro CP, Bicho M., Role of cellular magnesium in health and human disease. Front Biosci 2004; 9: 262-276.
29. Arendt J, Bojkowski C, Franey C, et al,. Immunoassay of 6-hydroxymelatonin sulphate in human plasma and urine: Abolition of the urinary 24-hour rhythm with atenolol. J Clin Endocrinol Metab 1985; 60: 1166-1173.
30. Chesson A Jr, Hartse K, Anderson WM, et al,. Practice parameters for the evaluation of chronic insomnia. An American Academy of Sleep Medicine report. Standards of Practice Committee of the American Academy of Sleep Medicine. Sleep 2000; 23: 237-241.
31. Yesavage JA, Brink TL, Rose TL, et al,. Development and validation of a geriatric depression screening scale: A preliminary report. J Psychiatr Res 1982-1983; 17: 37-49.
32. Folstein MF, Folstein SE, McHugh PR., "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975; 12: 189-198.
33. Katz S, Downs TD, Cash HR, et al,. Progress in development of the index of ADL. Gerontologist 1970; 10: 20-30.
34. Buysse DJ, Reynolds CF III, Monk TH, et al,. The Pittsburgh Sleep Quality Index: A new instrument for psychiatric practice and research. Psychiatry Res 1989; 28: 193-213.
35. Parrott AC, Hindmarch I., The Leeds Sleep Evaluation Questionnaire in psychopharmacological investigations-a review. Psycopharmacology 1980; 71: 173-179.
36. Tarrasch R, Laudon M, Zisapel N., Cross-cultural validation of the Leeds Sleep Evaluation Questionnaire (LSEQ) in insomnia patients. Hum Psychopharmacol 2003; 18: 603-610.
37. Vignatelli L, Plazzi G, Barbato A, et al,. Italian version of the Epworth Sleepiness Scale: External validity. Neurol Sci 2003; 23: 295-300.
38. Rosenthal L, Roehrs TA, Roth T., The Sleep-Wake Activity Inventory: A self-report measure of daytime sleepiness. Biol Psychiatry 1993; 34: 810-820.
39. Violani C, Devoto A, Lucidi F, et al,. Validity of a short insomnia questionnaire: The SDQ. Brain Res Bull 2004; 63: 415-421.
40. Miwa H, Sasahara S, Matsui T., Roll-over detection and sleep quality measurement using a wearable sensor. Conf Proc IEEE Eng Med Biol Soc 2007; 2007: 1507-1510.
41. Ware JE, Snow KK, Kosinski M, et al,. SF-36 Health Survey: Manual and Interpretation Guide. Boston: The Health Institute, 1993.
42. Guigoz Y, Vellas B, Garry PJ., Assessing the nutritional status of the elderly: The Mini Nutritional Assessment as part of the geriatric evaluation. Nutr Rev 1996; 54: 59-65.
43. Hughes RJ, Sack RL, Lewy AJ., The role of melatonin and circadian phase in age-related sleep-maintenance insomnia: Assessment in a clinical trial of melatonin replacement. Sleep 1998; 21: 52-68.
44. Nunes DM, Mota RM, Machado MO, et al,. Effect of melatonin administration on subjective sleep quality in chronic obstructive pulmonary disease. Braz J Med Biol Res 2008; 41: 926-931.
45. Waldhauser F, Saletu B, Trinchard-Lugan I., Sleep laboratory investigations on hypnotic properties of melatonin. Psychopharmacology 1990; 100: 222-226.
46. Hörnquist JO., Quality of life: Concept and assessment. Scand J Soc Med 1990; 18: 69-79.
47. Oztürk G, Akbulut KG, Afrasyap L., Age-related changes in tissue and plasma zinc levels: Modulation by exogenously administered melatonin. Exp Aging Res 2008; 34: 453-462.
48. Holliman BJ, Chyka PA., Problems in assessment of acute melatonin overdose. South Med J 1997; 90: 451-453.
49. Vgontzas AN, Bixler EO, Kales A, et al,. Validity and clinical utility of sleep laboratory criteria for insomnia. Int J Neurosci 1994; 77: 11-21.